SLC16A1 and brain neoplasm: An analysis of the REMBRANDT and TCGA databases of patient brain tumors revealed that SLC16A1 expression—the gene which encodes MCT1—was elevated in GBM compared with lower-grade astrocytoma, oligodendroma, and non-tumor brain samples [47].